← SynDRA
ECHINOMYCIN
SynDRA canonical compound SYN0016541 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | DNA intercalating agent |
Mechanisms of action (all sources)
Cross-references
Synonyms
- Levomycin
- Quinomycin A
- NSC526417
- MLS002702903
- Quinomycin A;NSC-13502
- S-426-S (Lepetit)
- NSC-526417
- SMR001566720
- Echinomycin A
- N,N'-(11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane-7,20-diyl)bis(quinoxaline-2-carboxamide)
- GNF-PF-1958
- NSC-13502
- N-[2,4,12,15,17,25-hexamethyl-27-methylsulfanyl-3,6,10,13,16,19,23,26-octaoxo-11,24-di(propan-2-yl)-20-(quinoxaline-2-carbonylamino)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexazabicyclo[12.12.3]nonacosan-7-yl]quinoxaline-2-carboxamide
- Quinomycin A (7CI,
- cid_3197
- Neuro_000224
- SCHEMBL63091
- Echinomycin (NSC-13502)
- CHEMBL263730
- DTXSID5031266
- BDBM93922
- Antibiotic C638-8, crystalline
- NSC13502
- MFCD00156105
- echinomycin (undefined stereochemistry)
- C 6388
- Q5332566
- 2-Quinoxalinecarboxmide,N'-[2,4,12,15,17,25-hexamethyl-~ 11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23~ ,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo [12.12.3]nonacosane-7,20-diyl]bis-
- 2-Quinoxalinecarboxmide,N'-[2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl) -27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa -28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosan e-7,20-diyl]bis-
- WLN: T C-16-6-16-/CE& A B C- C- 2CP E& AS CX C-S DNV GMV KOV NNV PXNV TMV A&OV D&NVTJ D1
- TG824J6RQT
- N,N'-((1R,4S,7R,11S,14R,17S,20R,24S)-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosane-7,20-diyl)bis(quinoxaline-2-carboxamide)
- UNII-TG824J6RQT
- SK-302B
- BRN 0078671
- ECHINOMYCIN [MI]
- ANTIBIOTIC A-654I
- 4-27-00-09726 (Beilstein Handbook Reference)
Look up ECHINOMYCIN in the interactive SynDRA portal →